Temaz and Hyperreflexia - a phase IV clinical study of FDA data

Summary:

Hyperreflexia is reported as a side effect among people who take Temaz (temazepam), especially for people who are female, 20-29 old, also take Oxycontin, and have Pain.

The phase IV clinical study analyzes which people have Hyperreflexia when taking Temaz. It is created by eHealthMe based on reports of 40,916 people who have side effects when taking Temaz from the FDA, and is updated regularly.

What is Temaz?

Temaz has active ingredients of temazepam. It is often used in insomnia. eHealthMe is studying from 42,293 Temaz users. Check the latest studies of Temaz.

What is Hyperreflexia?

Hyperreflexia (overactive or over responsive reflexes) is found to be associated with 426 drugs and 649 conditions by eHealthMe. Check the latest studies of Hyperreflexia.

On Jul, 15, 2026

40,916 people reported to have side effects when taking Temaz.
Among them, 32 people (0.08%) have Hyperreflexia.

Among these 32 people:

What is the gender of people who have Hyperreflexia when taking Temaz? *

female: 71.88 %
male: 28.12 %

What is the age of people who have Hyperreflexia when taking Temaz? *

What are other drugs people take besides Temaz? *

Oxycontin: 9 people, 28.12%
Ranitidine: 7 people, 21.88%
Oxycodone: 5 people, 15.62%
Thiamine: 4 people, 12.50%
Diazepam: 4 people, 12.50%
Lyrica: 4 people, 12.50%
Citalopram Hydrobromide: 4 people, 12.50%
Fentanyl: 4 people, 12.50%
Effexor: 3 people, 9.38%
Dyazide: 3 people, 9.38%

What are other side effects people have besides Hyperreflexia? *

Grand Mal Convulsion (a type of generalized seizure that affects the entire brain): 12 people, 37.50%
Skin Blushing/flushing (a sudden reddening of the face, neck): 12 people, 37.50%
Tremor (trembling or shaking movements in one or more parts of your body): 11 people, 34.38%
Serotonin Syndrome (occurs when two drugs that affect the body's level of serotonin are taken together at the same time): 11 people, 34.38%
Weakness: 10 people, 31.25%
Hyperhidrosis (abnormally increased sweating): 10 people, 31.25%
Nausea And Vomiting: 9 people, 28.12%
Drowsiness: 9 people, 28.12%
Confusional State: 8 people, 25.00%
Fever: 8 people, 25.00%

What are the existing conditions these people have? *

Pain: 8 people, 25.00%
Depression: 5 people, 15.62%
Sleep Disorder: 4 people, 12.50%
Postpartum Depression (depression suffered by a mother following childbirth): 3 people, 9.38%
Neuralgia (pain in one or more nerves): 3 people, 9.38%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 9.38%
High Blood Pressure: 3 people, 9.38%
Cellulitis (infection under the skin): 3 people, 9.38%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 1 person, 3.12%
Neoplasm Malignant (cancer tumour): 1 person, 3.12%

* Approximation only. Some reports may have incomplete information.

Do you take Temaz and have Hyperreflexia?

- Check whether Hyperreflexia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Temaz:

Temaz (42,293 reports)

Hyperreflexia treatments and more:

Hyperreflexia (4,677 reports)

Browse all side effects of Temaz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperreflexia:

Hyperreflexia (426 drugs)

Browse all the conditions that are associated with Hyperreflexia:

Hyperreflexia (649 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on temazepam (the active ingredients of Temaz) and Temaz (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.